To verify this phenomenon, the authors knocked down the key MMR gene MLH1 and established a dMMR mouse tumor model to further investigate the relationship between the cGAS-STING pathway and the effect of immunotherapy in patients with dMMR tumors [46]. Here, STING1 is linked to neoplasm.